Tipiralacil, also known as TPI, is a thymidine phosphorylase inhibitor (TPI). Tipiracil is one of the active components in TAS-102, which is an anticancer drug candidate currently in clinical trials.
TAS-102 is an antitumor agent composed of a combination of trifluorothymidine (FTD), a nucleoside that incorporates into DNA and inhibits a variety of genetic functions required for the proliferation of cancer cells, and tipiracil hydrochloride (TPI), an inhibitor of thymidine phosphorylase (which degrades FTD) that maintains an effective blood concentration of FTD. Tipiracil protects trifluridine from being broken down when taken orally.
Seebio also can supply Tipiracil intermediates as below:
PRODUCT NAME
|
CAS NO.
|
USAGE
|
5-Chloro-6-(chloromethyl)-2,4(1h,3h)-pyrimidinedione
|
73742-45-7
|
Tipiracil
|
3,4-dihydro-2H-pyrrol-5-amine hydrochloride (1:1)
|
7544-75-4
|
Tipiracil
|
6-(Chloromethyl)uracil
|
18592-13-7
|
Tipiracil
|
Thank you for your attention to Seebio Biotech (Shanghai) Co., Ltd.. If you’ve got any questions or comment, please
contact us by phone, fax or email, as well as in letter.